Recently, the combining of different drugs has greatly improved response and survival rates in
gynecological malignancies. Results are however far from being satisfactory. Treatments used in case of
advanced or recurrent disease offer limited results in terms of long-term responses. The urgent need for new
and more effective treatments has prompted researchers to investigate and propose new therapeutic
strategies. One of the most interesting approaches that are being explored is constituted by immunotherapy.
Currently, immunotherapeutic strategies include vaccination with peptide, viral vectors, carbohydrates and antiidiotypic
antibodies. In addition, cell based immunotherapy has been adopted in vitro activated lymphocytes
and dendritic cells. Most experience has been acquired in ovarian cancer and cervical cancer. Little has been
investigated in endometrial and rare gynecologic neoplasms.
The clinical experiences and results achieved with immunotherapy in this setting of patients have been
reviewed and the future avenues that are currently being explored have also been discussed.
Keywords: Anti-idiotypic antibody, cancer vaccine, cervical cancer, dendritic cells, gynecological cancer,
immunotherapy, lymphocytes, ovarian cancer
Rights & PermissionsPrintExport
Published on: 03 April, 2013
Page: [648 - 669]